CAR T-Cell Therapy Market

Global CAR T-Cell Therapy Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 - (By Product, By Indication, By End Use, By Geographic Coverage and By Company)

Published Date: Dec 2024 | Format: | No. of Pages: 191

Industry: Healthcare IT | Author Name: Sayali

Request Customisation / Information

FAQ : CAR T-Cell Therapy Market

The global market was valued at US$ 5.6 Bn in 2024.

Novartis has been a pioneer in CAR T-cell Therapy.

The industry is estimated to witness a CAGR of 22.5% from 2024 to 2031.

Increasing prevalence of blood cancer and regulatory support are driving the industry.

A key opportunity lies in rising investments by government bodies to enhance research.

Quality assured

Confidentiality assured

Custom research services

CAR T-Cell Therapy Market

Request Customisation / Information

FAQ : CAR T-Cell Therapy Market

What was the Market Size of CAR T-cell Therapy in 2024?

Who is the Pioneer in CAR T-cell Therapy?

What does the Future Hold for CAR T-cell Therapy?

Which Factors are Driving the Growth of the CAR T-cell Therapy Industry?

What is a Key Opportunity in the CAR T-cell Therapy Industry?